AzTrials
AzTrials

Calculi, UrinaryLITAPEDNCT06734403

Urinary Calculi After Bladder Augmentation in Children

An observational study of Calculi, Urinary and Neurogenic Bladder Disorder, run by University Hospital, Clermont-Ferrand at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study is to analyse the occurence of urinary calculi after bladder augmentation in children: location of the calculi (kidney or bladder) type of bladder augmentation with higher rate of urinary calculi and why Find risk factors of urinary calculi in bladder augmentation (age, sex, other… Read more about this study

Who is it for?
Ages 0 to 17 years
What is being tested?
Bladder Augmentation
How many people
34 participants
Where
1 siteFrance
Study dates
20 Nov 2022to 10 Apr 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Patients younger than 18 years old, with urinary calculi, after bladder augmentation.

Who may be able to join

  • Patients younger than 18 years old, with urinary calculi, after bladder augmentation

Who cannot join

  • Patients older than 18 years old, with urinary calculi, after bladder augmentation

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital, Clermont-Ferrand

    Clermont-Ferrand, Auvergne, 63003

Other trials in France

About this study

Official title: Management of Patients Who Had Urolithiasis After Bladder Augmentation in Childhood

The goal of this observational study is to analyse the occurence of urinary calculi after bladder augmentation in children:

  • location of the calculi (kidney or bladder)
  • type of bladder augmentation with higher rate of urinary calculi and why
  • Find risk factors of urinary calculi in bladder augmentation (age, sex, other bladder procedures..)
Read the detailed description

Study the data of patients younger than 18 years old, who underwent a bladder augmentation, complicated by urinary calculi.

Being tested
Bladder Augmentation
Keywords
Urinary Calculus, Bladder Augmentation, Child, Retrospective Study
Medical subject headings
Urinary Calculi, Urinary Bladder, Neurogenic, Spinal Dysraphism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bladder AugmentationOther

    Bladder Augmentation using bowel loop (ileal or sigmoid loop)

Study groups in NCT06734403
Study groupRoleWhat they receive
IleocystoplastyUrinary Calculi After Ileocystoplasty in Children
Receives: Other: Bladder Augmentation
SigmoidocystoplastyUrinary Calculi After Sigmoidocystoplasty in Children
Receives: Other: Bladder Augmentation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of participants with urinary calculi

    Rate of participants with urinary calculi After bladder augmentation

    Measured: Through study completion, an average of 2 years

  2. Location of urinary calculi in the participants

    After bladder augmentation, urinary calculi can be seen on postoperative imaging such as abdominal ultrasound, CT scan, and MRI. The different locations of these calculi can be the kidneys, the ureters, the bladder, or the urethra. Each patient who has had urinary calculi will be reported, and the location of the calculi will be specified depending on the imaging results.

    Measured: Through study completion, an average of 2 years

Secondary outcomes (3)
  1. Time frame between surgery and occurence of urinary calculi in the participants After bladder augmentation

    Time frame between surgery and occurence of urinary calculi in the participants After bladder augmentation

    Measured: Through study completion, an average of 2 years

  2. Management of urinary calculi after bladder augmentation in the participants

    3 main procedures help getting rid off urinary calculi: extracorporeal lithotripsy, endoscopic surgery or laparotomy. The patients were divided depending on the procedure that was used to remove the urinary calculi.

    Measured: Through study completion, an average of 2 years

  3. Risk factors of urinary calculi after bladder augmentation in the participants

    Age, sex, type of bladder augmentation...

    Measured: Through study completion, an average of 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Dec 2024
  2. Study start20 Nov 2022
  3. Primary completion31 Jan 2023
  4. Study completion10 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06734403
Sponsor's protocol ID
M24DC1104
Acronym
LITAPED
Status last verified
Dec 2024
First submitted
11 Dec 2024
Last updated
16 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: In the name of anonymization the investigators won't share individual participant data

Questions about this trial

What is this clinical trial studying?

An observational study of Calculi, Urinary and Neurogenic Bladder Disorder, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of participants with urinary calculi (time frame: Through study completion, an average of 2 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Dec 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in